At the time of writing, Cytek BioSciences Inc [CTKB] stock is trading at $6.37, up 5.99%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CTKB shares have gain 12.54% over the last week, with a monthly amount drifted -2.30%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cytek BioSciences Inc [NASDAQ: CTKB] stock has seen the most recent analyst activity on December 14, 2023, when Stephens initiated its Overweight rating and assigned the stock a price target of $9.
For the past year, the stock price of Cytek BioSciences Inc fluctuated between $3.80 and $12.31. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Cytek BioSciences Inc [NASDAQ: CTKB] shares were valued at $6.37 at the most recent close of the market. An investor can expect a potential return of 151.18% based on the average CTKB price forecast.
Analyzing the CTKB fundamentals
According to Cytek BioSciences Inc [NASDAQ:CTKB], the company’s sales were 193.01M for trailing twelve months, which represents an 20.48% jump. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at -0.14%, Pretax Profit Margin comes in at -0.08%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is -0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.98 points at the first support level, and at 5.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.65, and for the 2nd resistance point, it is at 6.94.
Cytek BioSciences Inc [CTKB] reported earnings per share of $0.04 for its fiscal quarter that ended on 12/31/2023. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.05 per share as compared to estimates of $0.03 per share, a difference of -$0.08 representing a surprise of -266.70%.
Ratios To Look Out For
It is important to note that Cytek BioSciences Inc [NASDAQ:CTKB] has a current ratio of 6.97. As well, the Quick Ratio is 5.89, while the Cash Ratio is 2.98. Considering the valuation of this stock, the price to sales ratio is 4.33, the price to book ratio is 2.12.
Transactions by insiders
Recent insider trading involved Yan Ming, CHIEF TECHNOLOGY OFFICER, that happened on Apr 19 ’24 when 20000.0 shares were sold. CHIEF TECHNOLOGY OFFICER, Yan Ming completed a deal on Apr 09 ’24 to sell 1900.0 shares. Meanwhile, CHIEF TECHNOLOGY OFFICER Yan Ming sold 20000.0 shares on Mar 19 ’24.
